Key takeaways:
Erleada (apalutamide) is a prescription medication that treats certain types of prostate cancer. It comes as an oral tablet and is typically dispensed through a specialty pharmacy.
On average, a 1-month supply of Erleada costs about $19282.53 without insurance. But the price you’ll pay may vary by pharmacy, dosage, and fill quantity.
Erleada is covered by most health insurance plans. But prior authorization is common, and some plans may require step therapy.
There are ways to save on Erleada, including a manufacturer copay savings card and a patient assistance program.
Save on related medications
Prostate cancer is often very treatable, especially when it’s found early. Still, starting treatment can raise several logistical concerns. Cost is often front and center. Even with insurance, prescription prices can be a big financial strain.
Erleada (apalutamide) is one medication your oncologist may prescribe. It’s an oral treatment used for certain types of prostate cancer. If you receive a prescription for it, you’ll also need treatment — medication or surgery — to bring down your testosterone levels.
Here’s what to know about the cost of Erleada without insurance, which factors can influence the price, and ways you may be able to lower your out-of-pocket expenses.
How much does Erleada cost?
Erleada is a brand-name-only tablet that comes in 2 doses, 60 mg and 240 mg. Most people take one 240 mg tablet once daily.
In some cases, your oncologist may have you take four 60 mg tablets once a day instead. This adds up to the same 240 mg daily dose. Using the 60 mg tablets can also make it easier to lower your dose if you have side effects. For example, your oncologist may tell you to take 1 or 2 fewer tablets each day.
In either case, you’ll keep taking Erleada until your cancer progresses or you experience side effects you can’t tolerate.
Below are the average retail prices for a 1-month supply of Erleada:
A generic version of Erleada was FDA approved in March 2025, but it isn’t available in U.S. pharmacies yet. It likely won’t be available for several years because of patent litigation.
Which factors affect the cost of Erleada?
What you’ll pay for Erleada depends on several factors, including:
Insurance: If you have health insurance, the cost of Erleada will depend on your plan’s cost-sharing requirements and coverage deals. You may have to pay out of pocket for a deductible, copays, or coinsurance.
Dosage: Erleada comes in two doses. The cost may differ depending on which dose you need and how much you fill at a time.
Pharmacy: Prices for Erleada can differ depending on which pharmacy you use. Specialty pharmacies typically dispense the medication, and the best deal may depend on which one your insurance prefers.
Location: Medication prices can vary by geography. For example, GoodRx research shows that people living in New Orleans may pay more for prescription medications than people living in Atlanta.
Discounts: You may be able to lower the cost of Erleada by using a manufacturer copay savings card or a patient assistance program.
Does insurance cover Erleada?
Erleada is covered by most health insurance plans. But across most plan types, prior authorization is often required. Step therapy may also apply in some cases. In other words, your oncologist may need to confirm that you meet your insurance plan’s requirements or that you’ve tried other treatments.
Because specific coverage rules can vary from plan to plan, the best way to see how your insurance covers Erleada is to check your plan’s formulary (its list of covered medications) or ask your insurer directly.
How different insurance plans cover Erleada
The table below breaks down the percentage of enrollees who have coverage for Erleada by insurance type. It also shows the likelihood of having prior authorization and step therapy requirements.
Insurance type | Enrollees covered for Erleada 240 mg tablets | Enrollees required to get prior authorization | Enrollees required to do step therapy |
|---|---|---|---|
91.6% | 88.3% | 2.3% | |
Commercial plans (excluding ACA plans) | 98.2% | 84.4% | 6.6% |
Medicare (Medicare Advantage and Part D plans) | 100% | 96.7% | 1.2% |
Medicaid, including state-run and managed care plans | 99.9% | 48% | 8.3% |
Source: Managed Markets Insight & Technology, LLC™, as of January 10, 2026 (See methodology below.)
If your insurance doesn’t cover Erleada, consider these options:
Request a formulary exception from your insurer. Your oncologist may need to submit paperwork and a letter of medical necessity explaining why Erleada is necessary.
If your insurer denies your formulary exception request, you have the right to file an appeal.
Check to see if you qualify for financial assistance through Erleada’s manufacturer copay savings card or patient assistance program.
Ask your oncologist about other prostate cancer medications that may be preferred by your plan or cost less out of pocket.
During the next open enrollment period for health insurance, look for a plan that offers better coverage for Erleada — especially if your prostate cancer seems to be responding well to the medication.
Ways to save on Erleada
Erleada can cost thousands of dollars if you don’t have insurance. But there are ways to lower your out-of-pocket costs with and without insurance. If you’re uninsured, you may even be able to get the medication at no cost. Here are four ways you could save.
1. See if you qualify for a copay savings card
With the J&J withMe Savings Program, some people with commercial insurance may pay as little as $0 per month for their Erleada prescription.
To qualify, you need to:
Have commercial insurance or a plan purchased through the ACA marketplace
Have an out-of-pocket cost for Erleada
Live in the U.S. or one of its territories
Have a valid Erleada prescription for an FDA-approved use
If you have Medicare, Medicaid, Tricare, or another government-funded insurance plan, you aren’t eligible for this program.
Good to know: If your pharmacy isn’t able to process this card at the time of filling, you should be able to submit a rebate request to the manufacturer.
2. Check if you’re eligible for a patient assistance program
If you don’t qualify for the copay savings card, you may be able to receive Erleada at no cost for up to 1 year through the Johnson & Johnson Patient Assistance Program. You can apply online, and eligibility is largely based on your insurance status and household income. Your oncologist or specialty pharmacy can also help you apply.
The main eligibility criteria include:
Be uninsured or underinsured
If you have Medicare Part D, prove you’re not eligible for Extra Help
Meet income requirements
Live in the U.S., Puerto Rico, or U.S. Virgin Islands
Have a valid Erleada prescription for an FDA-approved use from a U.S.-licensed healthcare professional
Independent patient assistance programs are another option to consider. A few examples include the HealthWell Foundation, Patient Advocate Foundation, and The Assistance Fund. Each one has its own eligibility criteria.
3. Ask about 90-day supplies
Some pharmacies and insurance plans offer discounts when you fill a 90-day supply of medication. In some cases, insurance plans also lower your copay or coinsurance if you use their preferred specialty mail-order pharmacy for a 90-day supply. By filling a larger amount up front, you may be able to lower your overall cost for Erleada over time.
Because these discounts can vary, it’s a good idea to check with your specialty pharmacy and insurance plan about your options. You should also talk with your oncologist about whether a 90-day supply makes sense for you. Depending on your treatment plan, shorter refills may be more appropriate.
4. Tap into your HSA, FSA, or HRA
If you have a health savings account (HSA), a flexible spending account (FSA), or a health reimbursement arrangement (HRA), you can use those tax-free dollars to cover the cost of Erleada.
FSA funds generally need to be spent by the end of the plan year. HSA funds work differently. They roll over each year and can be used anytime. HRAs often roll over too.
The bottom line
Erleada (apalutamide) is a prescription medication that treats certain types of prostate cancer. Without insurance, a standard 1-month supply of Erleada costs an average of $19282.53. Many insurance plans cover the medication, but prior authorization is usually required. Step therapy may also apply in some cases.
If paying for Erleada is a concern, don’t hesitate to ask about savings opportunities. Manufacturer copay cards and patient assistance programs may help reduce what you owe. Your oncologist, specialty pharmacy, and insurance company can help you understand your next steps.
Why trust our experts?
Methodology
We obtained national prescription coverage data for each medication from Managed Markets Insight & Technology (MMIT). The data reflects health insurance coverage as of January 2026.
We calculated the percentage of enrollees in plans that cover each medication by dividing the number of enrollees covered for the medication within a specific insurance channel (e.g., ACA, Medicare, Medicaid) by the total number of enrollees in all plans within that channel.
We determined the percentage of enrollees in plans with a prior authorization requirement by calculating the proportion of enrollees in plans that required prior authorization for the medication within each channel.
Finally, we measured the percentage of enrollees in plans with a step therapy requirement by calculating the proportion of enrollees in plans that imposed step therapy requirements for the medication in each channel.
These estimates, derived from national MMIT coverage data, provide insight into health insurance coverage for each medication. They take into account restrictions such as prior authorization, step therapy, and quantity limits. The percentages are expressed relative to the total number of enrollees covered by various insurance channels, including ACA plans, commercial (excluding ACA) plans, Medicare, and Medicaid (both state-run and managed care plans).
References
The Assistance Fund. (n.d.). Prostate cancer copay assistance program.
Erleada. (2025). J&J withMe. Johnson & Johnson.
HealthCare.gov. (n.d.). Appealing a health plan decision. Centers for Medicare & Medicaid Services.
HealthWell Foundation. (n.d.). Prostate cancer - Medicare access.
Janssen Products. (2025). Erleada- apalutamide tablet, film coated [package insert]. DailyMed.
Johnson & Johnson. (2025). Johnson & Johnson Patient Assistance Program - quick reference guide.
Johnson & Johnson. (2025). Specialty pharmacies and specialty distributors for Erleada (apalutamide).
Johnson & Johnson. (2026). J&J withMe document upload site.
Johnson & Johnson. (2026). Johnson & Johnson Patient Assistance Program.
Medicaid.gov. (n.d.). Managed care. Centers for Medicare & Medicaid Services.
Patient Advocate Foundation Co-Pay Relief. (n.d.). Prostate cancer.
Urology Care Foundation. (2025). What is prostate cancer? American Urological Association.
U.S. Food & Drug Administration. (2025). First generic drug approvals.
